|
PSMG2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.079400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.996200E-03 |
| Normal-vs-Stage2 |
7.880800E-01 |
| Normal-vs-Stage3 |
6.328000E-02 |
| Normal-vs-Stage4 |
5.336200E-02 |
| Stage1-vs-Stage2 |
1.988160E-02 |
| Stage1-vs-Stage3 |
5.020000E-01 |
| Stage1-vs-Stage4 |
6.039600E-01 |
| Stage2-vs-Stage3 |
1.055200E-01 |
| Stage2-vs-Stage4 |
1.077810E-01 |
| Stage3-vs-Stage4 |
9.118600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.736600E-03 |
| Normal-vs-AfricanAmerican |
9.384200E-01 |
| Normal-vs-Asian |
8.824300E-03 |
| Caucasian-vs-AfricanAmerican |
1.246200E-01 |
| Caucasian-vs-Asian |
3.380200E-01 |
| AfricanAmerican-vs-Asian |
4.918300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.447450E-04 |
| Normal-vs-Female |
6.138000E-02 |
| Male-vs-Female |
9.503400E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.540970E-03 |
| Normal-vs-Age(41-60Yrs) |
4.590000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.037000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.641600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.386440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.868230E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.157600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.088000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.340800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.962000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.027200E-01 |
| Classical-VS-Follicular |
1.162730E-03 |
| Classical-VS-Other |
1.791180E-01 |
| Classical-VS-Normal |
4.811600E-04 |
| Tall-VS-Follicular |
1.541840E-02 |
| Tall-VS-Other |
4.811200E-01 |
| Tall-VS-Normal |
1.477560E-02 |
| Follicular-VS-Other |
5.363700E-02 |
| Follicular-VS-Normal |
5.503600E-01 |
| Other-VS-Normal |
3.904400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.648600E-01 |
| Normal-vs-N1 |
7.356400E-03 |
| N0-vs-N1 |
5.991700E-02 |
|
|
